Standigm Companies
Standigm is an AI-driven workflow drug discovery company that aims to improve the success rates and efficiency of new drug development.
Investors
Founded Date:
2015-05-04
Total Funding:
71240000.0
Investor Type:
For Profit
Employee Number:
101-250
Funding Status:
Late Stage Venture
Technology:
Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Pharmaceutical
Last Funding Type:
Series D
Investors Number:
15.0
Last Funding Date:
2021-06-30
Industry:
BioTech & Health Care
Headquarters:
Seoul, Seoul-t'ukpyolsi, South Korea
Estimated Revenue:
$1M to $10M